IntelDrug is a Swiss-based consulting firm operating internationally that provides expert advisory services in drug design, artificial intelligence in drug design, analytical chemical structure identification and drug development.
Products, services, technology
IntelDrug services comprise: assessment of your current company's drug discovery strategy and its potential - selecting the needs-based combination of software and AI-enhanced know-how - creating and moving drug candidates to pre-clinical and clinical trials - analytical structure identification
Readily available to cooperate contractually (paid per hour/day/month) - Cost-effective pricing adaptable to financial resources (success fees, finder fees) - Possibility to represent your company at scientific workshops - Remote/hybrid/in situ (Switzerland) collaboration mode
IntelDrug makes drug discovery better and faster, answers unanswered questions about drug safety and efficacy, and creates digital health to personalize everyone's medicine.
IntelDrug's expertise spans AI-enhanced drug development methods, structure identifications, and respiratory drug delivery.
The unique set of skills and expertise spans the area of standard computational drug design up to state-of-the-art AI algorithms, from the pharma classic drug design to the novel biotech, lifestyle and wellness therapies design setup.
In addition to Computer-Assisted Drug Design, IntelDrug's strength is the drug development process, from the initial design phase to the final clinical trials, which comprises safety and regulatory assessment, toxicology testing, pharmacokinetic analysis and digital health applications.
Networking, finding needs to solve, finding clients.
Biotech, life sciences and pharmaceutical companies that need or wish to set up or speed up the drug discovery process. Plus finding investors for some of the startup clients.